ACLAX | VMVAX | ACLAX / VMVAX | |
Total Expense Ratio | 1.23 | 0.07 | 1,757% |
Annual Report Gross Expense Ratio | 1.23 | 0.07 | 1,757% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 6.820 | 5.532 | 123% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.09B | 30.6B | 23% |
Annual Yield % from dividends | 1.32 | 2.26 | 59% |
Returns for 1 year | 2.68 | 9.76 | 27% |
Returns for 3 years | 8.38 | 28.18 | 30% |
Returns for 5 years | 19.22 | 71.82 | 27% |
Returns for 10 years | 13.59 | 93.07 | 15% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFDIX | 55.59 | 0.29 | +0.52% |
American Century Large Cap Equity Inv | |||
FDIGX | 87.89 | 0.36 | +0.41% |
Fidelity Advisor Consumer Staples I | |||
FAMFX | 26.11 | 0.07 | +0.27% |
FAM Small Cap Investor | |||
NRDGX | 24.41 | 0.05 | +0.21% |
Neuberger Berman Dividend Growth R6 | |||
RERHX | 61.02 | -0.32 | -0.52% |
American Funds EUPAC R5E |